Abstract: This disclosure relates to a polymer that includes a first comonomer repeat unit containing a benzothiadiazole moiety, a thiophene oxide moiety, a cyclopentadithiophene oxide moiety, a thiadiazoloquinoxaline moiety, a benzoisothiazole moiety, a benzothiazole moiety, a thienothiophene moiety, a thienothiophene oxide moiety, a dithienothiophene moiety, a dithienothiophene oxide moiety, or a tetrahydroisoindole moiety. The polymer can be used as a photoactive material in a photovoltaic cell. This disclosure also relates to such photovoltaic cells, as well as modules containing such photovoltaic cells.

Abstract: This disclosure relates to a polymer containing a first comonomer repeat unit and a second comonomer repeat unit. The first comonomer repeat unit includes a cyclopentadithiophene moiety. The second comonomer repeat unit includes a thienothiophene moiety, a thienothiophene tetraoxide moiety, a dithienothiophene moiety, a dithienothiophene dioxide moiety, a dithienothiophene tetraoxide moiety, or a tetrahydroisoindole moiety. The polymer can be used as a photoactive material in a photovoltaic cell. This disclosure also relates to such photovoltaic cells, as well as modules containing such photovoltaic cells.

Abstract: The present invention relates to compounds of the formula I where Y, X1, X2, X3, R1, R2, A1, A2, Z1, Z2, m and n are as defined in Claim 1, to the use thereof as components in liquid-crystalline media, and to electro-optical display elements containing the liquid-crystalline media according to the invention.

Abstract: The invention relates to new thienothiophene derivatives, their use as semiconductors or charge transport materials, in optical, electrooptical or electronic devices like for example organic field effect transistors (FET or OFET) for thin film transistor liquid crystal displays and integrated circuit devices such as RFID tags, electroluminescent devices in flat panel displays, and in photovoltaic and sensor devices, and to a field effect transistor, light emitting device or ID tag comprising the thienothiophene derivatives.

Abstract: Compounds of formula (I) are novel P2X3 and P2X2/P2X3 containing receptor antagonists and are useful in treating pain, urinary incontinence, and bladder overactivity.

Abstract: The invention concerns compounds of formula (I) in which: A forms a tricyclic system of formula A1, A2, A3 or A4; R1 represents a hydrogen atom, an alkyl, hydroxy, alkoxy or oxo group; (R2)m and (R3)m′ are such as defined in the description; n represents an integer such that 0≦n≦3; p represents an integer such as defined in the description; B represents a group (a) or (b). The invention is useful for preparing medicines.

Abstract: The invention relates to a compound selected from these of formula (I): ##STR1## in which R.sub.7, R.sub.8, Y, n and A are as defined in the description, and medicinal product containing the same useful for treating a disorder of the melatoninergic system.

Abstract: A novel photochromic compound as a photoreactive material making use of photochromism is provided, which compound is expressed by the following formula (1) or (2)): ##STR1## wherein R is alkyl, alkoxy, perfluoroalkyl or cyano; X.sub.1, X.sub.2, X.sub.3, X.sub.4, X.sub.5 and X.sub.6 are each H, halogen, alkyl, alkoxy, cyano, alkanoyloxy or alkyloxycarbonyl, or a substituted or unsubstituted benzene ring is formed by condensation between at adjacent groups among X.sub.1 to X.sub.6 ; Y is Y.sub.1 C=CY.sub.2, O, S, SO, SO.sub.2 or NY.sub.3 wherein Y.sub.1 and Y.sub.2 are each as defined in the case of the above X.sub.1 to X.sub.6 and Y.sub.3 is H, alkyl, alkanoyl, alkyloxycarbonyl or aryl; and the symbol refers to occurrence of E- or Z-isomer, and which compound is useful as rewritable optical memory element or photo-display element and also as solar energy-storage material, duplicating material, masking material, optical filter, toys, etc.

Abstract: A process for the preparation of a polycyclic dye of the Formula (1): ##STR1## by reacting a substituted acetic acid of the Formula (2): ##STR2## with a compound of the Formula (3): ##STR3## and oxidation of the intermediate leuco compound to dehydrogenate the peripheral heterocyclic rings whereinY is an optionally substituted aromatic or heteroaromatic radical;Ring A is unsubstituted or is substituted by from one to five groups;Z is --NR.sup.1 R.sup.2 ;R.sup.1 and R.sup.2 are each independently H or are independently selected from optionally substituted alkyl, alkenyl, cycloalkyl, aralkyl, aryl and heteroaryl; orR.sup.1 and R.sup.2 together with the nitrogen atom to which they are attached form a heterocyclic ring; orR.sup.1 and R.sup.2 each independently together with the nitrogen to which they are attached and the adjacent carbon atom of Ring B form a heterocyclic ring; andX.sup.1 and X.sup.

Abstract: A photochromic compound represented by the following general formula [I] ##STR1## wherein ##STR2## represents a divalent aromatic hydrocarbon group or a divalent heterocyclic group each of which may have a substituent,R.sub.1 represents a monovalent hydrocarbon group or a monovalent heterocyclic group each of which may have a substituent, ##STR3## represents a norbornylidene or adamantylidene group which may have a substituent,X represents an oxygen atom or a group of the formula >N--R.sub.3 in which R.sub.3 represents a hydrogen atom or a hydrocarbon group which may have a substituent, andR.sub.2 represents a monovalent hydrocarbon group which may have a substituent.Also provided are a process for production of the photochromic compound, a composition containing the photochromic compound, and the use of the photochromic compound. The colored form of this photochromic compound has excellent thermal stability.

Abstract: The invention concerns heterocyclic nitromethane derivatives of the formula 1 as defined hereinafter (and their non-toxic salts) wherein the heterocyclic moiety Q is thienyl, benzothienyl or dibenzothienyl and may bear a wide variety of optional substituents, together with pharmaceutical compositions containing them. The nitromethane derivatives are inhibitors of the enzyme aldose reductase and are of value in the treatment of certain complications of diabetes and galactosemia.

Abstract: A novel series of polycyclic amines, derivatives, methods of making the compounds, novel intermediates, compositions containing them, and methods for using them in the treatment and prevention of cerebrovascular disorders are disclosed.

Abstract: Compounds of the general formula: ##STR1## wherein Z.sup.1 and Z.sup.2 are each independently --O--, --S-- or --NR.sup.5 -- in which R.sup.5 is hydrogen, an optionally substituted hydrocarbon group or an acyl group;X.sup.1 and X.sup.2 are selected from hydrogen, halogen, cyano, C.sub.1-4 alkyl, C.sub.1-4 alkoxy, aryl, carbamoyl, sulphamoyl, carboxy or carboxylic acid ester;R.sup.1 is an optionally substituted aryl radical;A is an optionally substituted alkyl radical or a radical of the formula:R.sup.2 --(CH.dbd.CH).sub.n --in whichR.sup.2 is an optionally substituted aryl or heterocyclic radical, andn has a value of 1 or 2.The compounds are useful as dyes for synthetic textile materials.

Abstract: Pharmaceutical preparations containing compounds of formula I ##STR1## wherein ring A is unsubstituted or substituted, R.sub.1 and R.sub.2, independently of one another, each represents hydrogen, lower alkyl, aryl or heteroaryl, or R.sub.1 and R.sub.2 together represent lower alkylene optionally interrupted by oxygen, sulfur or optionally substituted nitrogen, Y is methylene, methylene mono- or disubstituted by lower alkyl, oxygen, sulfur, sulfinyl or sulfonyl, X represents a bivalent radical --S--C[--B--(Z).sub.n ].dbd.CH-- the sulfur group S of which is bonded directly to the .alpha.- or to the .beta.

Abstract: A compound of the formula: ##STR1## wherein, Z.sup.1 and Z.sup.2 are each independently - O -, - S - or - NR.sup.5 - in which R.sup.5 is H or an optionally-substituted hydrocarbon group or an acyl group;X.sup.1 and X.sup.2 are selected from H, halogen, cyano, C.sub.1-4 -alkyl, C.sub.1-4 -alkoxy, aryl, carbamoyl, sulphamoyl, carboxylic acid or carboxylic acid ester;R.sup.1 to R.sup.4 are each independently selected from H, C.sub.1-4 -alkyl, C.sub.1-4 -alkoxy, C.sub.1-4 -alkenyl, halogen and the group - X - Y;X is - O - or - S -; andY is C.sub.2-10 -alkenyl provided that,the substituents on rings A and B are different when Z.sup.1 and Z.sup.2 are the same or that Z.sup.1 and Z.sup.2 are different when the substituents on rings A and B are the same,which is suitable for the coloration of synthetic textile materials and processes for its preparation.

Abstract: A novel hetero-polycyclic compound of the following formula, a method for its preparation and its use in the coloration of textile materials: ##STR1## wherein, Z.sup.1 & Z.sup.2 are each independently --O--, --S-- or --NR.sup.5 -- in which R.sup.5 is H or an optionally-substituted hydrocarbon group or an acyl group;X.sup.1 & X.sup.2 are selected from H, halogen, cyano, C.sub.1-4 -alkyl, C.sub.1-4 -alkoxy, aryl, carbamoyl, sulphamoyl, carboxylic acid or carboxylic acid ester;R.sup.1 to R.sup.4 are each independently selected from H, C.sub.1-4 -alkyl, C.sub.1-4 -alkoxy, C.sub.1-4 -alkenyl, halogen and the group --X--Y;X is --O-- or --S--; andY is a group of the formula: ##STR2## wherein: V & W are each independently H or optionally substituted alkyl;p is an integer from 1 to 3;q is 0 or 1;p+q is at least 2; andZ is OR.sup.6 or NR.sup.6 R.sup.7 when q=1;or Z is OR.sup.8 or SR.sup.8 when q=0;wherein:R.sup.